Literature DB >> 11291952

Fourier analysis of steady-state visual evoked potentials in subjects with normal and defective stereo vision.

B Johansson1, P Jakobsson.   

Abstract

The purpose of this work was to study the second harmonic in the steady state pattern visual evoked potential (ssVEP) to various stimulus frequencies in subjects with normal and defective binocularity. ssVEPs were elicited by 4 c/deg sinusoidal gratings, with temporal frequencies ranging from 5 to 20 Hz (exp. 1) and 15 to 27.5 Hz (exp. 2). Responses were Fourier analysed and power and phase of the second harmonic to stimulus frequency were measured. For power, binocular enhancement in a bimodal fashion was found both in normals and in subjects with defective binocularity. The power with binocular stimulation was significantly higher in the normal group in the high frequency domain. Latency, estimated from the phase-frequency function, was longer in the group with defective binocularity, but this was statistically significant only for the high frequency domain. The results suggest that a visual system with normal binocular function can follow a stimulus with high temporal frequency more accurately than a system with disturbed binocularity.

Mesh:

Year:  2000        PMID: 11291952     DOI: 10.1023/a:1002876804178

Source DB:  PubMed          Journal:  Doc Ophthalmol        ISSN: 0012-4486            Impact factor:   2.379


  17 in total

1.  Differentiation of VEP intermodulation and second harmonic components by dichoptic, monocular, and binocular stimulation.

Authors:  S Suter; P S Suter; D T Perrier; K L Parker; J A Fox; J S Roessler
Journal:  Vis Neurosci       Date:  1996 Nov-Dec       Impact factor: 3.241

2.  Developmental changes of pattern reversal visual evoked potentials.

Authors:  K Aso; K Watanabe; T Negoro; E Takaetsu; S Furune; I Takahashi; N Yamamoto; K Nomura
Journal:  Brain Dev       Date:  1988       Impact factor: 1.961

3.  Binocularity in the human visual evoked potential: facilitation, summation and suppression.

Authors:  P A Apkarian; K Nakayama; C W Tyler
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1981-01

4.  Binocular interaction and steady-state visual evoked potentials. I. A study in normal subjects and in subjects with defective binocular vision.

Authors:  B Bagolini; V Porciatti; B Falsini
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1988       Impact factor: 3.117

5.  Models of binocular luminance interaction evaluated using visually evoked potential and psychophysical measures: a tribute to M. Russell Harter.

Authors:  J V Odom; G M Chao
Journal:  Int J Neurosci       Date:  1995       Impact factor: 2.292

6.  Binocular VEP summation in infants and adults with abnormal binocular histories.

Authors:  S L Shea; R N Aslin; D McCulloch
Journal:  Invest Ophthalmol Vis Sci       Date:  1987-02       Impact factor: 4.799

7.  Reaction time as a measure of binocular interaction in human vision.

Authors:  R Blake; W Martens; A Di Gianfilippo
Journal:  Invest Ophthalmol Vis Sci       Date:  1980-08       Impact factor: 4.799

8.  Binocular interactions and steady-state VEPs. A study in normal and defective binocular vision (Part II).

Authors:  B Bagolini; B Falsini; S Cermola; V Porciatti
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1994-12       Impact factor: 3.117

9.  Binocular vision tested with visual evoked potentials in children and infants.

Authors:  G Amigo; A Fiorentini; M Pirchio; D Spinelli
Journal:  Invest Ophthalmol Vis Sci       Date:  1978-09       Impact factor: 4.799

10.  Luminance and color contrast sensitivity and VEP latency in subjects with normal and defective binocularity.

Authors:  B Johansson; P Jakobsson
Journal:  Eur J Ophthalmol       Date:  1997 Jan-Mar       Impact factor: 1.922

View more
  9 in total

1.  Binocular summation in visual evoked cortical potential in patients who have significantly different P100 peak latencies in their two eyes.

Authors:  Atsushi Mizota; Akiko Hoshino; Emiko Adachi-Usami; Naoya Fujimoto
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-09       Impact factor: 3.117

2.  Fourier-analysed steady-state VEPs in pre-school children with and without normal binocularity.

Authors:  Björn Johansson; Peter Jakobsson
Journal:  Doc Ophthalmol       Date:  2006-01       Impact factor: 2.379

3.  Steady-state contrast response functions provide a sensitive and objective index of amblyopic deficits.

Authors:  Daniel H Baker; Mathieu Simard; Dave Saint-Amour; Robert F Hess
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-01-29       Impact factor: 4.799

4.  Pattern visual evoked potentials for identifying malingering.

Authors:  I-Ting Sun; Jong-Jer Lee; Hsiu-Mei Huang; Hsi-Kung Kuo
Journal:  Doc Ophthalmol       Date:  2015-01-25       Impact factor: 2.379

5.  Characteristics of Pattern Visual Evoked Potential in Two Eyes with Varying Visual Acuity in One Eye and Forensic Application.

Authors:  Fu-Quan Jia; Yu-Guang Liang; Xin-Yuan Zhang; Fang-Liang Luo; Yan-He Xiong; Long-Long Cheng; Ji-Hui Liu
Journal:  Curr Med Sci       Date:  2018-04-30

6.  A comparison of the performance of three visual evoked potential-based methods to estimate visual acuity.

Authors:  Anne Kurtenbach; Hana Langrová; Andre Messias; Eberhart Zrenner; Herbert Jägle
Journal:  Doc Ophthalmol       Date:  2012-11-11       Impact factor: 2.379

7.  Diabetic Retinopathy Analysis.

Authors:  R Sivakumar; G Ravindran; M Muthayya; S Lakshminarayanan; C U Velmurughendran
Journal:  J Biomed Biotechnol       Date:  2005

8.  The Influence of the Stimulus Design on the Harmonic Components of the Steady-State Visual Evoked Potential.

Authors:  Benjamin Solf; Stefan Schramm; Maren-Christina Blum; Sascha Klee
Journal:  Front Hum Neurosci       Date:  2020-09-09       Impact factor: 3.169

9.  Short-term monocular patching boosts the patched eye's response in visual cortex.

Authors:  Jiawei Zhou; Daniel H Baker; Mathieu Simard; Dave Saint-Amour; Robert F Hess
Journal:  Restor Neurol Neurosci       Date:  2015       Impact factor: 2.406

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.